BioSpace News Archive

Sprout wanted the warning regarding alcohol to be completely removed but the FDA said it must remain, although with a caveat.

My Personal Therapeutics, a London based biotechnology company announced today that it has completed technology licensing and secured initial funding to transform cancer care. Investment was led by London based Startup Funding Club and independent international investors.

Wuhan, capital city of central China’s Hubei province, has attracted ten major healthcare industry companies, including Taikang Group and China Biotech, to participate in building its Health Industrial Park.

Swedish Orphan Biovitrum AB will publish its report for the fourth quarter and full year 2018.

Arrowhead Pharmaceuticals Inc. presented preclinical data at The International Liver Congress™ 2019, the annual meeting of the European Association for the Study of the Liver, demonstrating that sustained reduction of mutant Z-AAT protein by RNA interference substantially reversed the alpha-1 antitrypsin deficiency disease phenotype in the PiZ mouse model.

Senior leaders to provide insight into TerrAscend’s recent success and growth potential

Pivotal Phase 3 study is evaluating efficacy and safety of investigational regenerative skin tissue in adults with deep partial-thickness burns

Alexion Pharmaceuticals, Inc. announced that the Company will report its financial results for the first quarter ended March 31, 2019 before the US financial markets open on April 25, 2019.

Presentation of data from multiple preclinical studies from APX001 antifungal program

Science2Startup Symposium Will Take Place in Cambridge on April 23, 2019, at the Broad Institute of MIT and Harvard